Summary
Johnson & Johnson (JNJ) filed an 8-K on October 13, 2009, to report its third-quarter financial results for the period ending September 27, 2009. The filing primarily consists of a press release and supplementary financial data. Investors can find details on the company's sales performance and earnings for the quarter, which are crucial indicators of the company's operational health and profitability. The press release, attached as an exhibit, is the primary source of this information and should be reviewed for specific figures and management commentary on the quarter's performance. This report is essential for investors seeking to understand JNJ's financial trajectory and how its performance aligns with market expectations. The supplementary data provides a more detailed look at the company's financial condition, including comparative sales figures. Investors should pay close attention to any discussions of trends, segment performance, and forward-looking statements within the press release to gauge the company's outlook.
Key Highlights
- 1JNJ announced its third-quarter 2009 sales and earnings results on October 13, 2009.
- 2The filing is an 8-K Current Report, indicating a material event or change for the company.
- 3The primary information is contained within an attached press release dated October 13, 2009.
- 4Unaudited comparative supplementary sales data and condensed consolidated statements of earnings for the third quarter are provided as exhibits.
- 5Investors can review these documents to assess the company's financial performance for the quarter ending September 27, 2009.
- 6The report focuses on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.